Efficacy and Safety of a Low-Dose 21-Day Combined Oral Contraceptive Containing Ethinylestradiol 20μg and Drospirenone 3mg

被引：0

作者：

D. Cibula

U. Karck

H. G. Weidenhammer

J. Kunz

S. Alincic

J. Marr

机构：

[1] Charles University,Department of Obstetrics and Gynaecology, General Faculty Hospital

[2] University of Freiburg,Department of Obstetrics and Gynaecology

[3] Klarastr,undefined

[4] Hospital Zollikerberg,undefined

[5] Schering AG,undefined

[6] MDG G&A,undefined

来源：

Clinical Drug Investigation | 2006年 / 26卷

关键词：

Combine Oral Contraceptive; Contraceptive Efficacy; Drospirenone; Withdrawal Bleeding; Normal Menstruation;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Objective: The purpose of this study was to assess the efficacy and safety of a new low-dose oral contraceptive containing ethinylestradiol 20μg and drospirenone 3mg (EE 20μg/drsp 3mg).

引用

页码：143 / 150

页数：7

共 50 条

[41] A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism
Oner, Gokalp
Muderris, Iptisam Ipek
CONTRACEPTION, 2011, 84 (05) : 508 - 511
[42] Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 μg given for 24 days compared to a 21-day regimen.
Ellman, H
Archer, DF
FERTILITY AND STERILITY, 2005, 84 : S169 - S170
[43] Effects of an extended flexible regimen of an oral contraceptive pill containing 20 μg ethinylestradiol and 3 mg drospirenone on menstrual-related symptoms: a randomised controlled trial
Machado, Rogerio Bonassi
Pompei, Luciano Melo
Badalotti, Mariangela
Ferriani, Rui
Cruz, Achilles M.
Nahas, Eliana
Maia, Hugo, Jr.
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2017, 22 (01): : 11 - 16
[44] Drospirenone/Ethinylestradiol 3mg/20µg (24/4 Day Regimen)A Review of Its Use in Contraception, Premenstrual Dysphoric Disorder and Moderate Acne Vulgaris
Caroline Fenton
Keri Wellington
Marit D. Moen
Dean M. Robinson
Drugs, 2007, 67 : 1749 - 1765
[45] Drospirenone/ethinylestradiol 3mg/20μg (24/4 day regimen) -: A review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgaris
Fenton, Caroline
Wellington, Keri
Moen, Marit D.
Robinson, Dean M.
DRUGS, 2007, 67 (12) : 1749 - 1765
[46] CLINICAL TOLERANCE OF A COMBINED MONOPHASIC CONTRACEPTIVE AGENT CONTAINING A LOW-DOSE OF ETHINYLESTRADIOL AND GESTODENE IN ADOLESCENTS
LEONARD, F
GASPARD, U
THEUNISSEN, L
CURRENT MEDICAL RESEARCH AND OPINION, 1993, 13 (02) : 78 - 86
[47] CLINICAL-STUDIES WITH A NEW, LOW-DOSE ORAL-CONTRACEPTIVE COMBINATION, CONTAINING 0.150 MG DESOGESTREL AND 0.020 MG ETHINYLESTRADIOL - FOREWORD
ALAPIESSA, U
LOK, D
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1987, : 5 - 5
[48] Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 μg ethinylestradiol
Winkler, UH
Ferguson, H
Mulders, JAPA
CONTRACEPTION, 2004, 69 (06) : 469 - 476
[49] A 13-month multicenter clinical experience of a low-dose monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene in Latin American women
Bassol, S
Alvarado, G
Arreola, RG
Celis-Gonzalez, C
Peña, EP
Flores, JG
Ahued, JR
Ricalde, RL
Lopez, CR
Prieto, G
Gurucharri, C
Heredia, MG
Ortiz, OC
Percossi, G
Casa, PRF
Botto, E
Tozzini, RI
Botti, G
de Pierro, AN
Fernandez, M
Lastreto, E
Ñañez, M
de Oliveira, HC
Yazlle, MEDH
Silva, J
Calazar, G
Gomez, J
Penagos, G
Cifuentes, R
Torres, LA
Reyes-Marquez, R
Albrecht, G
CONTRACEPTION, 2003, 67 (05) : 367 - 372
[50] Latin American experience with two low-dose oral contraceptives containing 30 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol/150 μg desogestrel
Bassol, S
Alvarado, A
Celis, C
Cravioto, MC
Peralta, O
Montaño, R
Novelli, J
Albornoz, H
Kesseru, E
Soares, A
Petracco, A
Isaia, B
Mendes, J
Bahamondes, L
de Melo, NR
Reyes-Marquez, R
Albrecht, G
CONTRACEPTION, 2000, 62 (03) : 131 - 135

← 1 2 3 4 5 →